OLUDAMILOLA ABIDEMI OLAJIDE M.D.
Prescription History 1699730721
Internal Medicine - Hematology & Oncology in Raleigh, NC
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for OLUDAMILOLA ABIDEMI OLAJIDE M.D., an active Hematology & Oncology specialist practicing in Raleigh, NC. Our medical registry currently tracks 23 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 669 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamoxifen Citrate, which accounts for 140 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NC PrescribersVs. NC Avg |
|---|---|---|---|
| Tamoxifen Citrate | 140 | $22.03▼ below NC avg | ▲ More than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2024, this provider wrote 140 Medicare prescriptions for Tamoxifen Citrate, about 3.5 times the volume of the typical North Carolina prescriber of this medication (40.5). Medicare paid an average of $22.03 per fill, versus $24.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 323.5 30-Day Fills standardized to 30-day supplies 9,657 Days of Medication total across all patients in 2024 | |||
| Anastrozole | 90 | $13.77▼ below NC avg | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 90 Medicare prescriptions for Anastrozole, about 1.3 times the volume of the typical North Carolina prescriber of this medication (67.7). Medicare paid an average of $13.77 per fill, versus $17.24 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 206.9 30-Day Fills standardized to 30-day supplies 6,179 Days of Medication total across all patients in 2024 | |||
| Letrozole | 78 | $20.06▼ below NC avg | ▲ More than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 78 Medicare prescriptions for Letrozole, about 1.3 times the volume of the typical North Carolina prescriber of this medication (58.9). Medicare paid an average of $20.06 per fill, versus $20.36 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 177.6 30-Day Fills standardized to 30-day supplies 5,328 Days of Medication total across all patients in 2024 | |||
| ValacyclovirValacyclovir Hcl | 38 | $31.95▼ below NC avg | ▲ More than typical |
About Valacyclovir: Valacyclovir is used to treat infections caused by certain types of viruses. Show more ▾ In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES. In 2024, this provider wrote 38 Medicare prescriptions for Valacyclovir, about 1.6 times the volume of the typical North Carolina prescriber of this medication (24.1). Medicare paid an average of $31.95 per fill, versus $35.53 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 60 30-Day Fills standardized to 30-day supplies 1,800 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 37 | $8.94▼ below NC avg | ≈ Typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 37 Medicare prescriptions for Prochlorperazine Maleate, about 1.2 times the volume of the typical North Carolina prescriber of this medication (32.1). Medicare paid an average of $8.94 per fill, versus $12.61 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 37 30-Day Fills standardized to 30-day supplies 314 Days of Medication total across all patients in 2024 | |||
| Exemestane | 30 | $152.80 | ≈ Typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. A hormonal antineoplastic agent. In 2024, this provider wrote 30 Medicare prescriptions for Exemestane, about the same volume as the typical North Carolina prescriber of this medication (27.8). Medicare paid an average of $152.80 per fill, versus $131.86 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 67.8 30-Day Fills standardized to 30-day supplies 2,033 Days of Medication total across all patients in 2024 | |||
| Oxycodone Hcl | 28 | $3.57▼ below NC avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 28 Medicare prescriptions for Oxycodone Hcl, about a third of the volume of the typical North Carolina prescriber of this medication (67.1). Medicare paid an average of $3.57 per fill, versus $16.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 28 30-Day Fills standardized to 30-day supplies 209 Days of Medication total across all patients in 2024 | |||
| Imatinib Mesylate | 21 | $72.44▼ below NC avg | ≈ Typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2024, this provider wrote 21 Medicare prescriptions for Imatinib Mesylate, about the same volume as the typical North Carolina prescriber of this medication (23.2). Medicare paid an average of $72.44 per fill, versus $901.76 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| RevlimidLenalidomide | 18 | $20,658.79 | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 18 Medicare prescriptions for Revlimid, about half the volume of the typical North Carolina prescriber of this medication (42.1). Medicare paid an average of $20,658.79 per fill, versus $17,290.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 483 Days of Medication total across all patients in 2024 | |||
| CalquenceAcalabrutinib Maleate | 18 | $6,307.82▼ below NC avg | ▼ Less than typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Inhibits Bruton’s tyrosine kinase; has antineoplastic activity. In 2024, this provider wrote 18 Medicare prescriptions for Calquence, about 68% of the volume of the typical North Carolina prescriber of this medication (26.6). Medicare paid an average of $6,307.82 per fill, versus $13,807.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 18 30-Day Fills standardized to 30-day supplies 514 Days of Medication total across all patients in 2024 | |||
| Lenalidomide | 17 | $13,671.67▼ below NC avg | ▼ Less than typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 17 Medicare prescriptions for Lenalidomide, about a third of the volume of the typical North Carolina prescriber of this medication (42.6). Medicare paid an average of $13,671.67 per fill, versus $13,863.73 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 17 30-Day Fills standardized to 30-day supplies 476 Days of Medication total across all patients in 2024 | |||
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 15 | $8.96▼ below NC avg | ≈ Typical |
About Diphenoxylate-Atropine: This medication is used to treat diarrhea. Show more ▾ It helps to decrease the number and frequency of bowel movements. It works by slowing the movement of the intestines. Diphenoxylate is similar to opioid pain relievers, but it acts mainly to slow the gut. Atropine belongs to a class of drugs known as anticholinergics, which help to dry up body fluids and also slow gut movement. This medication should not be used to treat diarrhea caused by certain types of infection (such as C. difficile-associated diarrhea following antibiotic therapy). Talk to your doctor for more details. This medication is not recommended for use in children younger than 6 years due to an increased risk of serious side effects (such as breathing problems). In 2024, this provider wrote 15 Medicare prescriptions for Diphenoxylate-Atropine, about 78% of the volume of the typical North Carolina prescriber of this medication (19.2). Medicare paid an average of $8.96 per fill, versus $22.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 15 30-Day Fills standardized to 30-day supplies 87 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 15 | $6.10▼ below NC avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 15 Medicare prescriptions for Gabapentin, about 15% of the volume of the typical North Carolina prescriber of this medication (99.7). Medicare paid an average of $6.10 per fill, versus $15.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| JakafiRuxolitinib Phosphate | 15 | $9,980.10▼ below NC avg | ▼ Less than typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2024, this provider wrote 15 Medicare prescriptions for Jakafi, about half the volume of the typical North Carolina prescriber of this medication (28.1). Medicare paid an average of $9,980.10 per fill, versus $15,775.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
| Dexamethasone | 14 | $42.30 | ▼ Less than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 14 Medicare prescriptions for Dexamethasone, about half the volume of the typical North Carolina prescriber of this medication (30.4). Medicare paid an average of $42.30 per fill, versus $13.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17.8 30-Day Fills standardized to 30-day supplies 417 Days of Medication total across all patients in 2024 | |||
| KisqaliRibociclib Succinate | 13 | $9,514.04▼ below NC avg | ▼ Less than typical |
About Kisqali: Ribociclib is used to treat breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Inhibits both CDK4 and CDK6. In 2024, this provider wrote 13 Medicare prescriptions for Kisqali, about 60% of the volume of the typical North Carolina prescriber of this medication (21.6). Medicare paid an average of $9,514.04 per fill, versus $14,495.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2024 | |||
| VerzenioAbemaciclib | 13 | $14,657.95 | ▼ Less than typical |
About Verzenio: This medication is used to treat certain types of breast cancer. Show more ▾ Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. A cell cycle inhibitor. In 2024, this provider wrote 13 Medicare prescriptions for Verzenio, about 61% of the volume of the typical North Carolina prescriber of this medication (21.3). Medicare paid an average of $14,657.95 per fill, versus $14,585.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2024 | |||
| Hydroxyurea | 13 | $27.03 | ▼ Less than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2024, this provider wrote 13 Medicare prescriptions for Hydroxyurea, about a third of the volume of the typical North Carolina prescriber of this medication (34.8). Medicare paid an average of $27.03 per fill, versus $24.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34.3 30-Day Fills standardized to 30-day supplies 1,030 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 12 | $13.19▼ below NC avg | ▼ Less than typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 12 Medicare prescriptions for Ondansetron Odt, about half the volume of the typical North Carolina prescriber of this medication (26.5). Medicare paid an average of $13.19 per fill, versus $13.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 13 30-Day Fills standardized to 30-day supplies 200 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 11 | $7.07▼ below NC avg | ▼ Less than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 11 Medicare prescriptions for Ondansetron Hcl, about a third of the volume of the typical North Carolina prescriber of this medication (31.4). Medicare paid an average of $7.07 per fill, versus $10.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 11 30-Day Fills standardized to 30-day supplies 162 Days of Medication total across all patients in 2024 | |||
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $13.78▼ below NC avg | ▼ Less than typical |
About Lidocaine-Prilocaine: This medication contains 2 amide-type local anesthetics, lidocaine and prilocaine. Show more ▾ It is used on normal, unbroken skin or on the outer genital area to prevent pain before certain procedures such as inserting a needle, skin grafts, or skin laser surgery. It works by temporarily numbing the skin and surrounding area. Do not use this product in the ears. If this product alone cannot completely numb the area being treated, it may be used to numb the area before a lidocaine injection is given to provide enough pain relief for certain procedures (such as removal of genital warts). A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION. In 2024, this provider wrote 11 Medicare prescriptions for Lidocaine-Prilocaine, about half the volume of the typical North Carolina prescriber of this medication (22.2). Medicare paid an average of $13.78 per fill, versus $29.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 11 30-Day Fills standardized to 30-day supplies 284 Days of Medication total across all patients in 2024 | |||
| ImbruvicaIbrutinib | 11 | $15,364.70 | ▼ Less than typical |
About Imbruvica: This medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). A Btk protein inhibitor. In 2024, this provider wrote 11 Medicare prescriptions for Imbruvica, about half the volume of the typical North Carolina prescriber of this medication (25.7). Medicare paid an average of $15,364.70 per fill, versus $14,914.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2024 | |||
| Ibuprofen | 11 | $1.97▼ below NC avg | ▼ Less than typical |
About Ibuprofen: Ibuprofen is used to relieve pain from various conditions such as headache, dental pain, menstrual cramps, muscle aches, or arthritis. Show more ▾ It is also used to reduce fever and to relieve minor aches and pain due to the common cold or flu. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties In 2024, this provider wrote 11 Medicare prescriptions for Ibuprofen, about a third of the volume of the typical North Carolina prescriber of this medication (30). Medicare paid an average of $1.97 per fill, versus $8.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 11 30-Day Fills standardized to 30-day supplies 186 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for OLUDAMILOLA ABIDEMI OLAJIDE M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Raleigh, NC practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NC prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
